本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Enanta Pharmaceuticals Inc.

7.75
+0.10001.31%
盘后7.750.00000.00%16:11 EDT
成交量:11.47万
成交额:89.30万
市值:1.66亿
市盈率:-1.71
高:7.93
开:7.65
低:7.56
收:7.65
数据加载中...
2021/08/05

重要事件披露

8-K - Current report
2021/07/16

重要事件披露

8-K - Current report
2021/05/10

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/06

重要事件披露

8-K - Current report
2021/03/05

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/08

重要事件披露

8-K - Current report
2021/02/05

重要事件披露

8-K - Current report
2021/01/28

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/25

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/04

重要事件披露

8-K - Current report
2020/11/25

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/11/23

重要事件披露

8-K - Current report